Mr. Jeffrey Wayne Cowen, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2428 E Austin St, Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
Candy M Clark, P. T. Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 781 E Brenham St, Giddings, TX 78942 Phone: 979-542-0223 Fax: 979-542-1993 |
Mr. Mark Allen Jones, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2428 E Austin St, Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
Stephanie Louise Sanders, MS, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 283 E Railroad Ave, Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
Miss Whitney L Hamilton, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 283 E Railroad Row, Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
Deborah Jean Moore, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1181 N Williamson St, Giddings, TX 78942 Phone: 979-542-3611 |
Jones & Cowen Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 283 E Railroad Row, Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
Dr. Danielle Jones Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1205 County Road 211, Giddings, TX 78942 Phone: 979-716-2081 |
Camille Stancik, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 283 E Railroad Row, Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
Paul A Jurica Iii, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 283 East Railroad Ave., Giddings, TX 78942 Phone: 979-542-7300 Fax: 979-542-7373 |
News Archive
The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. However, these profiles produce huge amounts of data, and the volume alone creates unique analytical problems.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) - a rare disease for which there is no FDA-approved first-line therapy.
Bruker Corporation today reported financial results for the fourth quarter and year ended December 31, 2009.
Organizers of a 20-year global effort to eliminate a parasitic infection that is a leading cause of disability have an early victory to savor: a five-year Egyptian elimination campaign has mostly succeeded, according to a new report in the March 25 issue of The Lancet.
› Verified 8 days ago